EarningsQ3 2024 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q3 2024 Earnings Report

0 Followers

MX:ARWR Q3 2024 EPS Results

Actual EPS-$24.79

Consensus EPS-$9.50

Beat/MissMissed by -$15.29

One Year Ago EPS-$17.24

Actual Revenue$0.00

Expected Revenue$949.74M

Beat/MissMissed by -$949.74M

YoY Revenue Growth-100.00%

QuarterQ3 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-27.86 / -	-1.976	―
Aug 04, 2026	2026 (Q3)	-22.94 / -24.43	-22.633	-7.94% (-1.80)
May 07, 2026	2026 (Q2)	-19.67 / -16.70	49.396	-133.82% (-66.10)
Feb 05, 2026	2026 (Q1)	0.66 / 3.95	-24.968	115.83% (+28.92)
Nov 25, 2025	2025 (Q4)	-2.01 / -1.98	-24.429	91.91% (+22.45)
Aug 07, 2025	2025 (Q3)	-17.10 / -22.63	-24.788	8.70% (+2.16)
May 12, 2025	2025 (Q2)	-3.36 / 49.40	-18.322	369.61% (+67.72)
Feb 10, 2025	2025 (Q1)	-8.55 / -24.97	-22.273	-12.10% (-2.69)
Nov 26, 2024	2024 (Q4)	-20.12 / -24.43	-18.322	-33.33% (-6.11)
Aug 08, 2024	2024 (Q3)	-9.50 / -24.79	-17.244	-43.75% (-7.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed